Archives
-
GLP-1 (9-36) amide: GPCR Assay Workflow
2026-09-28
Build cleaner GLP-1 receptor signaling experiments with GLP-1 (9-36) amide, a peptide antagonist suited to receptor-selective cAMP and metabolic assays. This guide combines practical handling, concentration planning, high-throughput FRET design, and troubleshooting for studies of receptor cross-talk and type 2 diabetes biology.
-
Aurora A in Retinoblastoma: Evidence and Implications
2026-09-28
A 2024 study found elevated Aurora kinase A (AURKA) in human retinoblastoma and linked its expression to histopathologic features associated with high-risk disease. Tissue analyses and functional experiments support AURKA as a candidate therapeutic target, while leaving clinical benefit, treatment selection, and ocular delivery to be established.
-
Chuanxiong Cortex and Pith in CHD: Volatile Networks
2026-09-27
This study combines SPME-GC×GC-MS with network pharmacology and molecular docking to compare volatile constituents and predicted CHD-related mechanisms in Chuanxiong rhizome cortex and pith. Its central contribution is showing that these tissues have distinct chemical profiles and candidate target networks, offering a basis for more tissue-specific investigation—not proof of clinical efficacy or molecular action.
-
MK-5108 (VX-689): Aurora A Research Guide
2026-09-26
MK-5108, also known as VX-689, is a research compound described as a highly selective Aurora A kinase inhibitor with a reported Aurora A IC50 of 0.064 nM. Its pharmacology and reported xenograft result support experimental investigation of Aurora A, while human retinoblastoma findings provide target rationale—not direct evidence that MK-5108 treats retinoblastoma.
-
O6-Benzylguanine: Mapping MGMT to TMZ Response
2026-09-25
MGMT can shape alkylator response through both its expression and its repair activity. This article connects recent AP-2α findings in recurrent glioma with a practical framework for using O6-Benzylguanine to test direct MGMT inhibition, interpret DNA damage and viability readouts, and strengthen translational research without overstating preclinical evidence.
-
Stiffness-Driven Dentinogenesis via LAMB1–FAK–MEK
2026-09-25
This study links substrate mechanics to odontoblast-like cell behavior, identifying a LAMB1–FAK–MEK1/2 signaling axis associated with stiffness-promoted dentinogenesis. Its central contribution is to connect cell–material interactions with mineralization-related outcomes, offering a mechanistic framework for studying reparative dentin and designing dental biomaterials.
-
TCAIM Sets a Proteostasis Brake on OGDH
2026-09-24
A 2025 Molecular Cell study identifies the mitochondrial DNAJC co-chaperone TCAIM as a selective binding partner of OGDH that helps lower its protein abundance through HSPA9 and LONP1. The resulting reduction in OGDH complex activity alters mitochondrial metabolism, revealing protein turnover as a regulatory layer for a key TCA-cycle enzyme.
-
HotStart™ 2X Green qPCR Master Mix for Cell Assays
2026-09-24
A practical guide to using HotStart™ 2X Green qPCR Master Mix (SKU K1070) to investigate gene-expression changes alongside cell viability, proliferation, or cytotoxicity assays. Covers SYBR Green specificity, workflow setup, data interpretation, and evidence-based product selection without treating transcript levels as a direct measure of viable cell number.
-
Sulfamonomethoxine Toxicity Across Aquatic Species
2026-09-23
Huang and colleagues compared acute and chronic sulfamonomethoxine toxicity across algae, cladocerans, and medaka, addressing a gap in ecological evidence for an antibiotic used in aquaculture. Their results indicate that the tested microalgae were more sensitive than the cladocerans, supporting the use of multiple trophic groups when assessing aquatic risks.
-
EZ Cap™ Human PTEN mRNA (ψUTP) Guide
2026-09-23
EZ Cap™ Human PTEN mRNA (ψUTP) is an in vitro transcribed mRNA reagent designed for research on PTEN expression and PI3K/Akt signaling. Its Cap 1 structure, pseudouridine modification, poly(A) tail, and defined storage formulation support controlled studies of mRNA stability enhancement and tumor suppressor biology.
-
TRAP-1 Reactivates p53Y220C by Induced Proximity
2026-09-22
The bioRxiv preprint identifies TRAP-1, a chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcriptional activity. In pancreatic cancer cell models, this mechanism increased p21 and other p53 target genes while suppressing cell growth, with inactive proximity controls supporting a causal role for ternary-complex formation.
-
Flexible Phage Capture for CTC Cancer Subtyping
2026-09-22
The reference study uses mechanically flexible M13 phage nanofibers to improve circulating tumor cell capture while suppressing nonspecific white blood cell adsorption. Its combination of magnetic isolation and immunostaining distinguished breast cancer patients from healthy donors and supported subtype classification, illustrating how surface mechanics can complement molecular recognition in liquid biopsy workflows.
-
CKLF1, Stroke Repair, and Translational Probes
2026-09-21
A mechanistic analysis of CKLF1-driven neutrophil infiltration after ischemic stroke, the evidence supporting esculetin, and the disciplined use of ICI 118,551 hydrochloride as a hypothesis-generating pharmacology tool rather than an unvalidated stroke therapy.
-
Angiotensin II A1042: Practical Protocol Guide
2026-09-21
This guide explains how to use Angiotensin II (SKU A1042) for controlled receptor, vascular smooth muscle, cell-signaling, and chronic infusion workflows. It is intended for research optimization based on the product dossier and should not be treated as direct paper validation, a diagnostic reagent, or a medical treatment.
-
3-Deazaneplanocin (DZNep) Workflow Guide
2026-09-20
Build reproducible DZNep experiments by linking SAHH inhibition and EZH2-associated chromatin changes to apoptosis, proliferation, and sphere-forming phenotypes. This workflow helps distinguish direct target engagement from model-specific responses in AML, hepatocellular carcinoma, and liver-disease research.